Newsroom

Catch up on news from Cerapedics and our developments. Follow us on LinkedIn and X to keep up with all of the latest news.

April 24, 2026 Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft Arrow icon
January 13, 2026 Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use Arrow icon
December 17, 2025 Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft Arrow icon
July 8, 2025 Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval Arrow icon
June 23, 2025 Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion Arrow icon
September 24, 2024 Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use Arrow icon
January 5, 2024 Cerapedics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Arrow icon
January 4, 2024 Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion Arrow icon
October 17, 2023 Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98.6% Spine Fusion Rates in Patients Treated With i-FACTOR® Arrow icon
July 19, 2023 Cerapedics™ Announces Expansion of Headquarters to Support Growth of its Bone Graft Products Arrow icon